TransMedics Group, Inc. — Director's Dealing 2024

Feb 27, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-02-23

Reporting Person: Khayal Tamer I (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-23	Common Stock	A	12127	$0.00	Acquired	26502	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-23	Stock Option (Right to Buy)	$83.14	A	18690	Acquired	2034-02-23	Common Stock (18690)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14776	Indirect
Common Stock	11051	Indirect

Footnotes

F1: Consists of 12,127 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 23, 2024 until the option is fully vested on February 23, 2028, subject to continued service.